Company Overview and News

 
7 A-Rated Materials Stocks to Buy | InvestorPlace

2018-04-13 investorplace
Materials stocks run the gamut. But whether a firm is making steel, refining oil and gas or making distilled spirits, the fact is, in an expanding economy these companies are in very good positions.
Upvote Downvote

 
NDRO / Enduro Realty Trust / Kent Jerry Roger - SC 13G/A (Passive Investment)

2018-02-12 sec.gov
SC 13G/A     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)*     Enduro Royalty Trust (Name of Issuer) Units of Beneficial Interest (Title of Class of Securities) 29269K100 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d
Upvote Downvote

 
NDRO / Enduro Realty Trust / Kent Jerry Roger - SC 13G/A (Passive Investment)

2018-02-12 sec.gov
SC 13G/A     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)*     Enduro Royalty Trust (Name of Issuer) Units of Beneficial Interest (Title of Class of Securities) 29269K100 (CUSIP Number) December 31, 2017 (Date of Event which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d
Upvote Downvote

 
NDRO / Enduro Realty Trust / Kent Jerry Roger - SC 13G (Passive Investment)

2017-11-09 sec.gov
SC 13G     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G (Amendment No.    )* Under the Securities Exchange Act of 1934     Enduro Royalty Trust (Name of Issuer) Units of Beneficial Interest (Title of Class of Securities) 29269K100 (CUSIP Number) November 3, 2017 (Date of Event which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-
Upvote Downvote

 
NDRO / Enduro Realty Trust - Stock Institutional Ownership and Shareholders - Fintel.io

2017-11-09 fintel.io
Enduro Realty Trust (NYSE:NDRO) has 26 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 20,589,408 shares. Largest shareholders include Riverstone Holdings Llc, Carlyle Group L.P., Kent Jerry Roger, RR Advisors, LLC, and Botty Investors LLC.
Upvote Downvote

 
NDRO / Enduro Realty Trust / Kent Jerry Roger - SC 13G (Passive Investment)

2017-11-09 sec.gov
SC 13G     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G (Amendment No.    )* Under the Securities Exchange Act of 1934     Enduro Royalty Trust (Name of Issuer) Units of Beneficial Interest (Title of Class of Securities) 29269K100 (CUSIP Number) November 3, 2017 (Date of Event which Requires Filing of this Statement)     Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-
Upvote Downvote

 
Pacific Coast Oil Royalty Trust: Attractive On A Risk/Reward Basis

2016-11-04 seekingalpha
Bad news for expansion plans of the Pacific Coast Energy Company put ROYT in a tailspin down.
Upvote Downvote

 
Monthly Pay Dividend Dog Yields From 13.2% To 34.3% From Top 10 As Of Sept. 4, 2015

2016-11-02 seekingalpha
September monthly pay (MoPay) dividend stocks dropped to 57 active ranging in yield from 0.51% to 34.29%.
Upvote Downvote

 
Monthly Pay Dividend Stocks: Your Lists For January

2016-09-20 seekingalpha
Monthly paying dividend (MoPay) entities compose three lists: 1. Stocks by yield (10/54); 2. Stocks by price upside (10/30); 3. Funds, Trusts & Preferreds (FTPs) by yield (10/60).
Upvote Downvote

 
10 Monthly Pay Dividend Dogs Average 45% Upsides And 61% Net Gains As Of November 20, 2016

2016-09-19 seekingalpha
Analysts predicted 1-year 25.59% to 118.34% upsides, and 34.89% to 172.93% net gains for the top 10 monthly pay Small, Mid, and Large dogs as of November 20, 2016.
Upvote Downvote

 
Your Monthly Pay Dividend Dog March Metrics

2016-09-19 seekingalpha
Monthly paying dividend (MoPay) entities comprise three lists for March: 1. Stocks by yield (10/53); 2. Stocks by price upside (10/30); 3. Funds, Trusts & Preferreds (FTPs) by yield (10/60).
Upvote Downvote

 
Energy Royalty Trusts This December Could Be The Gift That Keeps On Giving For Many Holiday Seasons

2016-09-18 seekingalpha
Buy a group of select Energy Royalty Trusts, and size the position like a perpetual option. If/when energy prices do climb, the income stream will be significant.
Upvote Downvote

 
Monthly Dividend Stocks: 3 Lists To Check Twice (It's December!)

2016-09-18 seekingalpha
December's monthly paying dividend (MoPay) entities comprised three lists: 1. Stocks by yield (10/53), 2. Stocks by price upside (10/30), and 3. Funds and Trusts (FT) by yield (10/60).
Upvote Downvote

 
Will Your Oil And Gas Trust Survive To See Higher Prices?

2016-09-17 seekingalpha
Some trusts should be priced at a discount because they will terminate unless commodity prices rise.
Upvote Downvote

 
Enduro Royalty Trust EX-32.1

2016-04-28 sec.gov
EXHIBIT 32.1   April 28, 2016   Via EDGAR   Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549   Re: Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002   Ladies and Gentlemen:   In connection with the Quarterly Report of Enduro Royalty Trust (the “Trust”) on Form 10-Q for the quarter ended March 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersig
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 29269K100